Skip to content

Pre-Tax Income at other companies

Everest Group logo
Everest GroupEG
$736M+197%
SiriusPoint logo
SiriusPointSPNT
$121.5M+61.4%
KKR & Co. logo
KKR & Co.KKR
$462.89M-40.0%
Skyward Specialty Insurance Group, Inc. logo
Skyward Specialty Insurance Group, Inc.SKWD
$62.08M+20.7%
Selective Insurance Group logo
Selective Insurance GroupSIGI
$124.2M-10.6%
Tiptree Inc. logo
Tiptree Inc.TIPT

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-71.3%
Enterprise value$184.93M-52.3%
P/E1.2×
P/S1.6×-27.7×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's pre-tax income?
King Pharmaceuticals (KG) reported pre-tax income of -$6.95M in Q1 2026.
How has King Pharmaceuticals's pre-tax income changed year-over-year?
King Pharmaceuticals's pre-tax income decreased by 2200.0% year-over-year, from -$302K to -$6.95M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.